This report documents the cloning and sequencing of a previously unkno
wn intron of the Her-2/neu gene and compares three different cloning s
trategies for efficient PCR cloning. Although successful results have
previously been documented using blunt-end ligation strategies, the TA
cloning system (Invitrogen, CA) offered the best result in our hands
using a PCR-amplified DNA fragment of Her-2/neu (ERBB2) gene containin
g an unreported intron. The TA cloning system is easy to manipulate an
d the cloned DNA can be easily sequenced without further subcloning in
to the M13 vector. Additionally, this cloning strategy does not requir
e (i) any prior selection of restriction sites during primer design, (
ii) post PCR restriction digestion, and/or (iii) gel purification of P
CR-amplified DNA. The newly identified and sequenced DNA of the Her-2/
neu intron (GenBank Accession No. M95667) may help in designing primer
s for the analysis of the Her-2/neu gene in biological specimens. Ther
efore, we recommend the TA cloning system as the preferred choice for
cloning any DNA fragments generated by PCR.